DRW Securities’s SteadyMed Ltd STDY Stock Holding History

DRW Securities’s Portfolio STDY Stock Details STDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20,000	Closed	-$65K	–	187
2018 Q1	$65K	Hold	20,000	–	–	﹤0.01%	155
2017 Q4	$74K	Buy	+20,000	New	+$64.6K	0.01%	443

Other funds holding STDY

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

DRW Securities's STDY Position: Q2 2018 in Review

DRW Securities sold out of SteadyMed Ltd (STDY) in Q2 2018, closing a stake of 20,000 shares — an estimated $65K sold.

DRW Securities first reported a position in STDY in Q4 2017 and held it in 2 quarters. The position peaked at $74K in Q4 2017. 30 funds tracked by Wall St. Rank hold STDY as of Q2 2018.

DRW Securities reported no remaining SteadyMed Ltd position as of Q2 2018 after selling out during the quarter.
DRW Securities sold 20,000 SteadyMed Ltd shares in Q2 2018, an estimated $65K.
DRW Securities first reported a position in SteadyMed Ltd in Q4 2017 and held it in 2 quarters.
DRW Securities's SteadyMed Ltd position peaked at $74K in Q4 2017.
30 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q2 2018.

Based on DRW Securities's 13F filing for Q2 2018, filed 14 Aug 2018.